Welcome to our dedicated page for BRF SA SEC filings (Ticker: BRFS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page compiles U.S. SEC filings for BRF S.A. (BRFS), a Brazilian food processing company in the animal (except poultry) slaughtering industry. As a foreign private issuer, BRF has used several SEC forms over time, giving investors a structured view of its financial reporting, capital markets activity and changes in U.S. listing status.
BRF files Annual Reports on Form 20-F, which include audited financial statements and other disclosures in English. News releases confirm that Form 20-F has been filed for multiple fiscal years with both the U.S. Securities and Exchange Commission and the Brazilian Securities Commission, with Portuguese translations made available in Brazil. Shareholders are informed that they may request hard copies of the audited financial statements filed with the SEC at no cost.
The company also furnishes Form 6-K reports, which transmit notices to the market, joint material facts and minutes of meetings of the board of directors. Recent 6-K filings list exhibits such as a joint material fact disseminated in Brazil by BRF and Marfrig and minutes of board meetings held in September 2025, offering additional context on corporate decisions and communications.
BRF’s interaction with U.S. capital markets is further documented through filings and related disclosures concerning its senior notes. Public communications describe cash tender offers for several series of notes, including 4.875% Senior Notes due 2030, 4.75% Senior Notes due 2024, 4.350% Senior Notes due 2026, 5.875% Senior Notes due 2022, 2.750% Senior Notes due 2022 and 3.95% Senior Notes due 2023. While the detailed terms are set out in offer to purchase documents, these activities are part of the broader filing and disclosure record.
Two key filings mark changes in BRF’s U.S. reporting and listing status. A Form 25 (25-NSE) dated September 23, 2025 records the removal of BRF’s American Depositary Shares from listing and registration on the New York Stock Exchange. A subsequent Form 15 (15-12G) dated October 3, 2025 certifies the termination of registration under Section 12(g) or suspension of the duty to file reports under Sections 13 and 15(d) for BRF’s common shares represented by American Depositary Shares, relying on Rule 12h-3(b)(1)(i).
On Stock Titan, these filings are presented with AI-powered summaries that help explain the role of each form—whether it is a comprehensive annual report, a current report on Form 6-K, a Form 25 delisting notice or a Form 15 deregistration filing. Real-time updates from EDGAR, combined with simplified explanations, enable users to quickly understand BRF’s regulatory history, its historical NYSE ADS listing, and its ongoing disclosures as a foreign private issuer.
BRF S.A. has disclosed that three Saudi-related investors now report no beneficial ownership of its common shares. SALIC International Investment Company, Saudi Agricultural and Livestock Investment Company, and The Public Investment Fund each report 0 common shares beneficially owned, representing 0% of BRF’s outstanding common shares. This means they no longer count as beneficial owners of BRF stock under U.S. reporting rules.
The filing is labeled as Amendment No. 2 and is also being used to correct an administrative error in the prior amendment. The signatory for The Public Investment Fund on Amendment No. 1 is clarified to have been Ahmad Alfilimbany, Head of Investment Operations Department, instead of the previously listed individual. The current amendment is signed by Sulaiman AlRumaih as Chief Executive Officer and by Ahmad Alfilimbany in his role at The Public Investment Fund.
Amendment No. 1 to Schedule 13D reports that SALIC Investment executed a public sale of 185,556,900 common shares of BRF S.A. at a net price of approximately R$19.96 per share via an auction on B3, which settled on September 4, 2025. Concurrent with the sale, SALIC entered a cash-settled derivative referencing the same 185,556,900 shares with an unaffiliated dealer, including an upfront payment by SALIC and ongoing non-refundable fees. The derivative permits SALIC to elect cash settlement prior to expiry and is scheduled to expire on September 2, 2026. As a result of the disposition, the reporting persons ceased to be beneficial owners of more than 5% of BRF common shares.
BRF S.A. (Ticker: BRFS) is the subject of a Form 25 notification filed with the Securities and Exchange Commission to remove a class of its securities from listing and/or registration on the New York Stock Exchange LLC. The form certifies that the Exchange and the issuer have complied with the procedural rules under 17 CFR 240.12d2-2 governing withdrawal or removal.
The filing provides no financial data, timing, or explanation for the removal; it only confirms the procedural certification by the Exchange and references the Commission file number 001-15148.